IZOZF
Izotropic Corporation, a MedTech company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and 3D CT breast imaging platform for the earlier detection and diagnosis of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q3 | -0.00 | $0 | -$157,466 |
| 2025 Q2 | -0.01 | $0 | -$342,723 |
| 2025 Q1 | -0.00 | $0 | -$159,092 |
| 2025 Q4 | -0.02 | $0 | -$240,770 |
| 2025 Q3 | -0.01 | $0 | -$209,441 |
| 2024 Q2 | -0.01 | $0 | -$82,586 |
| 2024 Q1 | -0.02 | $0 | -$104,573 |
| 2024 Q4 | 0.00 | $0 | -$26,763 |